Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$15.71 - $23.49 $59,446 - $88,886
3,784 Added 29.67%
16,537 $373,000
Q2 2024

Aug 02, 2024

SELL
$19.45 - $37.37 $27,521 - $52,878
-1,415 Reduced 9.99%
12,753 $248,000
Q1 2024

Apr 29, 2024

BUY
$36.08 - $54.3 $162,792 - $245,001
4,512 Added 46.73%
14,168 $531,000
Q4 2023

Jan 29, 2024

BUY
$34.32 - $57.55 $62,393 - $104,625
1,818 Added 23.19%
9,656 $540,000
Q3 2023

Oct 30, 2023

SELL
$40.86 - $62.98 $105,949 - $163,307
-2,593 Reduced 24.86%
7,838 $323,000
Q2 2023

Aug 02, 2023

BUY
$50.96 - $58.72 $4,127 - $4,756
81 Added 0.78%
10,431 $582,000
Q1 2023

May 03, 2023

BUY
$35.33 - $55.79 $4,946 - $7,810
140 Added 1.37%
10,350 $577,000
Q4 2022

Feb 14, 2023

BUY
$24.4 - $41.3 $74,273 - $125,717
3,044 Added 42.48%
10,210 $372,000
Q3 2022

Dec 13, 2022

BUY
$28.48 - $52.59 $11,619 - $21,456
408 Added 6.04%
7,166 $204,000
Q2 2022

Aug 11, 2022

BUY
$36.95 - $82.41 $56,939 - $126,993
1,541 Added 29.54%
6,758 $306,000
Q1 2022

May 16, 2022

BUY
$55.7 - $145.79 $74,136 - $194,046
1,331 Added 34.25%
5,217 $397,000
Q4 2021

Feb 11, 2022

BUY
$135.05 - $182.59 $216,080 - $292,144
1,600 Added 69.99%
3,886 $579,000
Q3 2021

Nov 01, 2021

BUY
$145.58 - $192.14 $332,795 - $439,232
2,286 New
2,286 $333,000
Q3 2021

Oct 25, 2021

SELL
$145.58 - $192.14 $316,927 - $418,288
-2,177 Closed
0 $0
Q2 2021

Jul 19, 2021

BUY
$134.22 - $202.37 $3,758 - $5,666
28 Added 1.3%
2,177 $426,000
Q1 2021

May 17, 2021

BUY
$140.25 - $196.86 $93,967 - $131,896
670 Added 45.3%
2,149 $389,000
Q4 2020

Jan 28, 2021

BUY
$126.47 - $163.7 $187,049 - $242,112
1,479 New
1,479 $209,000
Q3 2011

Nov 14, 2022

BUY
N/A
408
7,166 $204,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.17B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Perigon Wealth Management, LLC Portfolio

Follow Perigon Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perigon Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perigon Wealth Management, LLC with notifications on news.